# Synergene Therapeutics Inc.

Canonical: https://abierto.us/vendors/synergene-therapeutics-inc-w8e3g5851jk4

- UEI: W8E3G5851JK4
- CAGE: 43DC1
- Location: Potomac, MD
- Awards in window: 1 (4 transactions), $2,280,239 obligated, February 29, 2024 to February 11, 2025

## Awarding agencies

- Defense Threat Reduction Agency: 1 awards, $2,280,239

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $2,280,239

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- HDTRA120C0045 (definitive contract): $2,280,239, Defense Threat Reduction Agency. Application of a Nanocomplex Technology to Permeate the Blood Brain Barrier. https://www.usaspending.gov/award/CONT_AWD_HDTRA120C0045_9700_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/synergene-therapeutics-inc-w8e3g5851jk4.